ZAMO', Alberto
 Distribuzione geografica
Continente #
NA - Nord America 6.477
EU - Europa 4.813
AS - Asia 3.551
SA - Sud America 411
AF - Africa 42
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 15.317
Nazione #
US - Stati Uniti d'America 6.404
GB - Regno Unito 1.630
CN - Cina 1.417
SG - Singapore 1.350
IT - Italia 515
SE - Svezia 443
FR - Francia 433
DE - Germania 421
RU - Federazione Russa 377
FI - Finlandia 372
BR - Brasile 349
HK - Hong Kong 349
IE - Irlanda 281
UA - Ucraina 132
KR - Corea 99
VN - Vietnam 87
BE - Belgio 60
TR - Turchia 51
CA - Canada 49
IN - India 37
NL - Olanda 37
JP - Giappone 34
ES - Italia 25
IR - Iran 20
AR - Argentina 18
ID - Indonesia 18
MX - Messico 17
BD - Bangladesh 16
PL - Polonia 15
AT - Austria 14
ZA - Sudafrica 14
AU - Australia 13
EC - Ecuador 11
IL - Israele 11
CL - Cile 10
IQ - Iraq 9
CH - Svizzera 8
LT - Lituania 7
NP - Nepal 7
RO - Romania 7
VE - Venezuela 7
AZ - Azerbaigian 6
JO - Giordania 6
PK - Pakistan 6
UZ - Uzbekistan 6
CO - Colombia 5
CZ - Repubblica Ceca 5
DZ - Algeria 5
A2 - ???statistics.table.value.countryCode.A2??? 4
MA - Marocco 4
AL - Albania 3
BG - Bulgaria 3
BO - Bolivia 3
CI - Costa d'Avorio 3
EE - Estonia 3
EG - Egitto 3
EU - Europa 3
HU - Ungheria 3
LU - Lussemburgo 3
LV - Lettonia 3
MY - Malesia 3
PE - Perù 3
PY - Paraguay 3
BY - Bielorussia 2
GT - Guatemala 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AQ - Antartide 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CY - Cipro 1
ET - Etiopia 1
GE - Georgia 1
GN - Guinea 1
GR - Grecia 1
HR - Croazia 1
JM - Giamaica 1
KH - Cambogia 1
LY - Libia 1
MG - Madagascar 1
MK - Macedonia 1
MU - Mauritius 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
RW - Ruanda 1
Totale 15.312
Città #
Southend 1.480
Jacksonville 990
Chandler 824
Dallas 716
Singapore 654
Woodbridge 524
Ann Arbor 466
Hong Kong 345
Ashburn 313
Dublin 281
Houston 263
Beijing 251
Wilmington 157
Lawrence 143
Princeton 143
Jinan 121
Nanjing 118
New York 105
Verona 97
Shenyang 91
Los Angeles 89
Munich 89
The Dalles 75
Hebei 70
Helsinki 69
Sindelfingen 67
Brussels 60
Tianjin 59
Buffalo 58
Boardman 56
Ningbo 56
Nanchang 54
Columbus 53
Turku 49
Haikou 41
Zhengzhou 39
Changsha 36
Milan 36
Taizhou 34
Jiaxing 33
Dearborn 32
Hangzhou 32
Guangzhou 29
Redondo Beach 27
Tokyo 27
Bologna 26
Taiyuan 26
Fairfield 24
San Francisco 24
Norwalk 23
Ho Chi Minh City 21
Redmond 21
Seoul 21
Chicago 20
Lancaster 20
São Paulo 20
Groningen 19
Santa Clara 19
Falls Church 18
Frankfurt am Main 17
Rome 17
Fuzhou 15
Moscow 15
Jakarta 14
Toronto 14
Redwood City 13
Rio de Janeiro 13
Hanoi 12
Johannesburg 12
Madrid 12
Montreal 12
Seattle 12
Stockholm 12
Brasília 11
Council Bluffs 11
Dongguan 11
Düsseldorf 11
Kent 11
Leawood 11
Washington 11
Brooklyn 10
Dong Ket 10
Lanzhou 10
Zanjan 10
Amsterdam 9
Belo Horizonte 9
Clearwater 9
Phoenix 9
Warsaw 9
Wuhan 9
London 8
Mexico City 8
Paris 8
Torino 8
Augusta 7
Boston 7
Cambridge 7
Catania 7
Chennai 7
Qingdao 7
Totale 10.089
Nome #
Leucemia linfatica cronica/linfoma linfocitico (LLC): l'espressione di ZAP-70, analizzata alla diagnosi su biopsia ossea, è un importante fattore prognostico 283
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 260
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 189
Chromium-induced diffuse dermatitis with lymph node involvement resulting from Langerhans cell histiocytosis after metal-on-metal hip resurfacing 183
B-cell chronic lymphocytic leukemia cells espress functional death receptor 3 following stimulation of the B cell receptor 182
Espressione di TP73L nei linfomi B a grandi cellule primitivi del mediastino: un utile marcatore diagnostico 178
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 178
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 167
Detection of allele-specific gene expression on next generation sequencing data 162
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 162
EXPRESSION AND FUNCTIONAL ACTIVITY OF DEATH RECEPTOR 3 IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 161
[Primary large B cell non-Hodgkin's lymphoma of the mediastinum] 161
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 160
Espressione di marcatori di migrazione e invasività nei foci fibroblastici nella fibrosi polmonare idiopatica 159
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 157
Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis 154
Endothelin-1 receptor blockade as new possible therapeutic approach in multiple myeloma. 154
Application of a commercial software to the analysis of infrared structural images on lymph node tissues: a preliminary study 153
CD10 is expressed in a subset of chromophobe renal cell carcinomas 151
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 150
Analysis of colorectal cancers for human cytomegalovirus presence 148
ALK-positive anaplastic large cell lymphoma with PAX-5 expression: report of a case 146
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 146
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 143
slan+ monocytes and macrophages mediate CD20-dependent B cell lymphoma elimination via ADCC and ADCP 143
A Rare Disorder in an Orphan Disease: Kikuchi Fujimoto Disease in a Young-Adult Patient with Sickle Cell Anemia 142
Hairy cell leukemia in kidney transplantation: lesson from a rare disorder. 141
Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma. 139
The TNF-Family Cytokine TL1A Inhibits Proliferation of Human Activated B Cells 139
Establishment of the MAVER -1 cell line, a model for leukemic and aggressive mantle cell lymphoma. 136
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant 135
Mantle cell lymphoma cell lines show no evident immunoglobulin heavy chain stereotypy but frequent light chain stereotypy 134
A 6-GENE EXPRESSION SIGNATURE IN MANTLE CELL LYMPHOMA: RESULTS FROM THE FONDAZIONE ITALIANA LINFOMI (FIL)-MCL-0208 TRIAL 133
FPA micro spectral imaging of non-Hodgkin lymphomas 128
Microfluidic Deletion/Insertion Analysis for Rapid Screening of KIT and PDGFRA Mutations in CD117-Positive Gastrointestinal Stromal Tumors: Diagnostic Applications and Report of a New KIT Mutation. 127
The role of disease causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL. 126
In Vitro and In Vivo Model of EBV-Positive Non-Hodgkin Plasmablastic Lymphoma with Focal Plasmacytic Differentiation 124
Haploidentical hematopoietic stem cell transplantation in a myelofibrosis patient with primary graft failure 124
PEROXIREDOXIN-2: A NOVEL REGULATOR OF IRON HOMEOSTASIS IN INEFFECTIVE ERYTHROPOIESIS 123
Induction of apoptosis in Jeko-1 mantle cell lymphoma cell line by resveratrol: a proteomic analysis. 122
Application of Microfluidic Technology to the BIOMED-2 Protocol for Detection of B-Cell Clonality 121
Improvement of maternal and fetal outcomes in women with sickle cell disease treated with early prophylactic erythrocytapheresis 121
Identification of the core phosphoproteome of mantle cell lymphoma cell lines 118
Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling. 118
Evaluation of S-phase fraction as a prognostic marker in mantle cell lymphoma 118
Use of a Chip-based microfluidic apparatus in the analytic step of the Biomed-2 protocol for the detection of B-cell clonality 115
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death 115
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathway as a potential therapeutic target. 115
EXPRESSION AND FUNCTIONAL ACTIVITY OF THE TNFR-SUPERFAMILY MEMBER DEATH RECEPTOR 3 IN CHRONIC LYMPHOCYTIC LEUKEMIA B CELLS ACTIVATED BY THE BCR 115
The impact of sensitive KIT D816V detection on recognition of Indolent Systemic Mastocytosis 114
Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis 114
THE TNF-FAMILY CYTOKINE TL1A/DEATH RECEPTOR 3 FUNCTIONAL AXIS MODULATES B- CELL CHRONIC LYMPHOCYTIC LEUKEMIA PROLIFERATION 113
Signal transduction pathways of mantle cell lymphoma: a phosphoproteome-based study. 113
An unusual case of sarcoidosis in an adult patient with sickle cell disease: Management with methotrexate and low dose of steroid 112
Short-term, intensive chemotherapy regimen is equally effective in Burkitt lymphoma (BL) and in the novel WHO 2008 entity “B-cell lymphoma intermediate between DLBCL and BL". 112
The TNF-Family Cytokine TL1A/Death Receptor 3 System Reduces Metabolic Activity in Chronic Lymphocytic Leukemia B Cells 112
In reply to Schäfer et al: new evidence on the role of endothelin-1 axis as a potential therapeutic target in multiple myeloma 112
Activated KIT hyperexpression in thymic carcinoma: a potential target for therapeutic intervention. 111
GREY ZONES OF HODGKIN LYMPHOMA: REPORT OF A CASE WITH FEATURES INTERMEDIATE BETWEEN PRIMARY MEDIASTINAL B-CELL LYMPHOMA, CLASSICAL HODGKIN LYMPHOMA AND NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA 111
Constitutive expression of DeltaN-p63alpha isoform in human thymus and thymic epithelial tumours 110
VR09 Cell Line: An EBV-Positive Lymphoblastoid Cell Line with In Vivo Characteristics of Diffuse Large B Cell Lymphoma of Activated B-Cell Type 110
MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways 109
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathwayn as a potential therapeutic target 108
ALK-mediated activation of STAT3 elicits growth and anti-apoptotic signals. 107
Metodi e tecniche dell'anatomia patologica 107
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 106
HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis 105
CD16 expression in T-cell lymphomas: analysis on paraffin embedded tissues using the 2H7 antibody. 105
PHOSPHOSCAN ANALYSIS OF MANTLE CELL LYMPHOMA CELL LINES 105
Anaplastic lymphoma kinase in human cancer 105
Tissue proteomics of splenic marginal zone lymphoma 105
Phosphoproteome profiling of mantle cell lymphoma cell lines 104
Anaplastic large-cell lymphoma 104
Application of a commercial software to the analysis of infrared spectral images on lymph node tissues: a preliminary study. 103
Group 3 innate lymphoid cells regulate neutrophil migration and function in human decidua 102
Utilizzo dell'analisi microfluidica per il rilevamento di mutazioni dei geni KIT e PDGFRA nei tumori dello stroma gastroenterico. 100
Utilizzo di un apparato microfluidico per il rilevamento del riarrangiamento clonale dei geni delleimmunoglobuline secondo il protocollo BIOMED-2 100
Resveratrol activity on MCL cell line jeko-1: a proteomic approach 100
Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer. 99
Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas 98
The mantle cell lymphoma website: a free web-based resource for mantle cell lymphoma researchers 98
Modified HyperCVAD and rituximab for the treatment of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. 97
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis 97
ATM Deficiency Sensitizes Mantle Cell Lymphoma Cells to Poly(ADP-Ribose) Polymerase-1 Inhibitors 96
HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis 94
Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas 94
Classical Hodgkin lymphoma cells may promote an IL-17-enriched microenvironment 93
Identification of a three-gene model as a powerful diagnostic tool for the recognition of ALK negative ALCL 90
Quantitative evaluation of differential expression of p63 isoforms in primary mediastinal B-cell lymphomas by real-time PCR 89
Induction of apoptosis in Jeko-1 mantle cell lymphoma cell line by resveratrol : a proteomic analysis 89
Precise sequance analysis of rearranged immunoglobulin genes in mantle cell lymphoma cell lines 89
TCL1A expression in marginal zone lymphoma: a clinico-pathological evaluation in paired spleen and bone marrow samples 89
The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletion 88
Genome-Wide Promoter Methylation Profiling Of Splenic Marginal Zone Lymphoma (SMZL) Identifies Two Subgroups Of Patients With Distinct Genetic and Biologic Features and Different Outcomes 87
Models for quantitative individual grading and prognosis in breast malignancies 86
Molecular characterization of composite mantle cell and follicular lymphoma 85
Stat3 and Ras activation are required for the cellular transformation mediated by NPM-ALK 84
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. 84
MicroRNA signatures and Foxp3+ cell count correlate with relapse occurrence in follicular lymphoma 84
Impacts: planning a European initiative for standardized protein analysis of archival clinical tissues 83
Totale 12.371
Categoria #
all - tutte 54.404
article - articoli 30.126
book - libri 0
conference - conferenze 23.380
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 898
Totale 108.808


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021919 0 0 0 147 162 140 17 95 89 20 202 47
2021/20221.198 99 398 5 96 44 28 13 76 47 41 105 246
2022/20232.380 174 241 248 438 223 523 16 141 275 20 53 28
2023/20241.095 59 102 78 145 132 178 42 74 15 48 146 76
2024/20252.799 135 230 87 474 122 78 132 89 468 172 251 561
2025/20261.837 590 489 672 86 0 0 0 0 0 0 0 0
Totale 15.441